Diabetes patients who were taking metformin before contracting Covid-19 had dramatically different outcomes.

Long-acting insulins seem to be the best choice for elderly patients diagnosed with type 2 diabetes.

Researchers discovered that dapagliflozin helped patients with and without diabetes in improving kidney disease.

A recent study evaluated how diabetes status, A1C, and gender influence the risk of myocardial infarction (MI).

Data analysis suggests that patients with prediabetes have a similar risk for declines in brain function to patients diagnosed with diabetes.

Researchers analyzed participants in five continents to determine the association between glycemic index and cardiovascular disease.

Type 1 diabetes increases the risk of premature death from cardiovascular disease.

Intensive glucose-lowering techniques can have positive outcomes in patients >65 years.

Researchers found that every ten mmHg increase in systolic blood pressure observed was associated with an increased risk of cardiovascular diseases. 

Study found children with a new diagnosis of type 1 diabetes experienced higher rates of diabetic ketoacidosis in the COVID-19 pandemic.